Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 283

1.

The role of Syk in peripheral T cells.

Park JE, Majumdar S, Brand DD, Rosloniec EF, Yi AK, Stuart JM, Kang AH, Myers LK.

Clin Immunol. 2018 Jul;192:50-57. doi: 10.1016/j.clim.2018.04.007. Epub 2018 Apr 16.

PMID:
29673901
2.

Pediatric Weight Errors and Resultant Medication Dosing Errors in the Emergency Department.

Hirata KM, Kang AH, Ramirez GV, Kimata C, Yamamoto LG.

Pediatr Emerg Care. 2017 Oct 2. doi: 10.1097/PEC.0000000000001277. [Epub ahead of print]

PMID:
28976456
3.

The Role of Leukocyte-Associated Ig-like Receptor-1 in Suppressing Collagen-Induced Arthritis.

Kim S, Easterling ER, Price LC, Smith SL, Coligan JE, Park JE, Brand DD, Rosloniec EF, Stuart JM, Kang AH, Myers LK.

J Immunol. 2017 Oct 15;199(8):2692-2700. doi: 10.4049/jimmunol.1700271. Epub 2017 Sep 8.

PMID:
28887430
4.

Characterization of the Syk-Dependent T Cell Signaling Response to an Altered Peptide.

Park JE, Rotondo JA, Cullins DL, Brand DD, Yi AK, Stuart JM, Kang AH, Myers LK.

J Immunol. 2016 Dec 15;197(12):4569-4575. Epub 2016 Nov 11.

5.

Peptide ligand structure and I-Aq binding avidity influence T cell signaling pathway utilization.

Myers LK, Cullins DL, Park JE, Yi AK, Brand DD, Rosloniec EF, Stuart JM, Kang AH.

Clin Immunol. 2015 Oct;160(2):188-97. doi: 10.1016/j.clim.2015.05.002. Epub 2015 May 14.

6.

Acute exacerbation of dysphagia due to foreign body impaction in an oesophageal stricture due to eosinophilic esophagitis.

Kang JY, Kang AH, Amin Z, Chong H.

BMJ Case Rep. 2015 Mar 12;2015. pii: bcr2014208616. doi: 10.1136/bcr-2014-208616.

7.

Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis.

Tang B, Kim S, Hammond S, Cullins DL, Brand DD, Rosloniec EF, Stuart JM, Postlethwaite AE, Kang AH, Myers LK.

Arthritis Res Ther. 2014 Jan 10;16(1):R7. doi: 10.1186/ar4433.

8.

Systematic review: worldwide variation in the frequency of coeliac disease and changes over time.

Kang JY, Kang AH, Green A, Gwee KA, Ho KY.

Aliment Pharmacol Ther. 2013 Aug;38(3):226-45. doi: 10.1111/apt.12373. Epub 2013 Jun 18. Review.

9.

Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.

Kimata M, Cullins DL, Brown ML, Brand DD, Rosloniec EF, Myers LK, Stuart JM, Kang AH.

Arthritis Res Ther. 2012 May 8;14(3):R107. doi: 10.1186/ar3832.

10.

Molecular basis for T cell response induced by altered peptide ligand of type II collagen.

Park JE, Cullins D, Zalduondo L, Barnett SL, Yi AK, Kleinau S, Stuart JM, Kang AH, Myers LK.

J Biol Chem. 2012 Jun 1;287(23):19765-74. doi: 10.1074/jbc.M112.349688. Epub 2012 Apr 16.

11.

Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis.

Zhou B, Yuan J, Zhou Y, Ghawji M Jr, Deng YP, Lee AJ, Lee AJ, Nair U, Kang AH, Brand DD, Yoo TJ.

Clin Immunol. 2011 Dec;141(3):328-37. doi: 10.1016/j.clim.2011.08.014. Epub 2011 Sep 2.

PMID:
21944669
12.

T cells stimulated with an analog peptide of type II collagen require the Fc receptor γ-chain to secrete interleukin-4 and suppress autoimmune arthritis in mice.

Myers LK, Cullins DL, Brand DD, Kleinau S, Stuart JM, Kang AH.

Arthritis Rheum. 2011 Sep;63(9):2661-70. doi: 10.1002/art.30454.

13.

Modulation of collagen-induced arthritis by adenovirus-mediated intra-articular expression of modified collagen type II.

Tang B, Cullins DL, Zhou J, Zawaski JA, Park H, Brand DD, Hasty KA, Gaber MW, Stuart JM, Kang AH, Myers LK.

Arthritis Res Ther. 2010;12(4):R136. doi: 10.1186/ar3074. Epub 2010 Jul 8.

14.

Collagen-induced arthritis.

Rosloniec EF, Cremer M, Kang AH, Myers LK, Brand DD.

Curr Protoc Immunol. 2010 Apr;Chapter 15:Unit 15.5.1-25. doi: 10.1002/0471142735.im1505s89.

PMID:
20376842
15.

T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk.

Tang B, Zhou J, Park JE, Cullins D, Yi AK, Kang AH, Stuart JM, Myers LK.

Clin Immunol. 2009 Oct;133(1):145-53. doi: 10.1016/j.clim.2009.06.006.

16.

Accuracy of a reformulated fast-set vinyl polysiloxane impression material using dual-arch trays.

Kang AH, Johnson GH, Lepe X, Wataha JC.

J Prosthet Dent. 2009 May;101(5):332-41. doi: 10.1016/S0022-3913(09)60066-4.

PMID:
19410067
17.

Genetic and molecular basis of quantitative trait loci of arthritis in rat: genes and polymorphisms.

Xiong Q, Jiao Y, Hasty KA, Stuart JM, Postlethwaite A, Kang AH, Gu W.

J Immunol. 2008 Jul 15;181(2):859-64.

18.

A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.

Postlethwaite AE, Wong WK, Clements P, Chatterjee S, Fessler BJ, Kang AH, Korn J, Mayes M, Merkel PA, Molitor JA, Moreland L, Rothfield N, Simms RW, Smith EA, Spiera R, Steen V, Warrington K, White B, Wigley F, Furst DE.

Arthritis Rheum. 2008 Jun;58(6):1810-22. doi: 10.1002/art.23501.

19.

An altered peptide ligand of type II collagen suppresses autoimmune arthritis.

Myers LK, Tang B, Rosioniec EF, Stuart JM, Kang AH.

Crit Rev Immunol. 2007;27(4):345-56.

PMID:
18197813
20.

The effects of interleukin-18 on rat articular chondrocytes: a study of mRNA expression and protein synthesis of proinflammatory substances.

Ye XJ, Tang B, Ma Z, Zhou J, Myers LK, Kang AH, Cremer MA.

Clin Exp Immunol. 2007 Sep;149(3):553-60. Epub 2007 Jul 10.

Supplemental Content

Loading ...
Support Center